Clinical Trials Directory

Trials / Unknown

UnknownNCT01487746

Presence of Minor Anti Phospholipid Antibodies in Blood Samples of Ischemic Stroke Patients and Healthy Controls

Presence of Minor Anti Phospholipid Antibodies in Blood Samples of Ischemic Stroke Patients and Healthy Controls.

Status
Unknown
Phase
Study type
Observational
Enrollment
207 (estimated)
Sponsor
Meir Medical Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The investigators expect to find higher levels of both classical and minor antiphospholipid (APL) antibodies among the stroke cases. Furthermore, the investigators expect to find not only classical APLA but also minor antibodies. The investigators believe that minor antibodies have a major role in the hypercoagulability state.

Conditions

Timeline

Start date
2011-12-01
Primary completion
2012-03-01
Completion
2012-09-01
First posted
2011-12-07
Last updated
2011-12-07

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT01487746. Inclusion in this directory is not an endorsement.

Presence of Minor Anti Phospholipid Antibodies in Blood Samples of Ischemic Stroke Patients and Healthy Controls (NCT01487746) · Clinical Trials Directory